Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FTA00
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,347
Award facts
- Contract value 100% obligated
- $38,346.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, valued at $38,346.96, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products for Department of Defense healthcare facilities. The contract includes no set-aside designation, allowing DMS to compete directly in the federal marketplace based on its established capabilities as a pharmaceutical supplier.
Alecensa, an oncology medication used in the treatment of certain lung cancers, reflects DMS Pharmaceutical Group's specialized role in supplying branded pharmaceutical products to military and federal healthcare systems nationwide. The delivery order is scheduled for completion by October 14, 2025, with performance taking place at the company's facility in Park Ridge, Illinois. This award exemplifies DMS Pharmaceutical Group's significant positioning within the federal pharmaceutical supply chain, as the company has consistently secured contracts with DLA across diverse medical product categories ranging from specialty medications to biologics and medical consumables.
Quick answers
Who was awarded contract SPE2DB25FTA00?
SPE2DB25FTA00 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FTA00 worth?
The government has obligated $38,347 on SPE2DB25FTA00.
Is contract SPE2DB25FTA00 an order under another contract?
Yes. SPE2DB25FTA00 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA00 competed?
The extent of competition for SPE2DB25FTA00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award